you’re right, best is to send an email off to the guys and ask them directly.
I’d like to ask you about some other matters. I have been researching lately, and did not find much. really of interest to me at the moment is
A ) how many treatments we have in Spain and I think we have four so far ( are there any more) and
B ) what the status is of the approval / commencement of the G-BA / OSPREY study in Germany ( which leads to immediate paid treatments within the study) , and
[ the german Google keyword is “Erprobungsstudie” ]
c) if there are any new treatments yet in Belgium and UK.
with your deep research skills maybe you can find more than I did, just wondering
my guess is as soon as we can have more treatments going in Europe it will create a very positive effect
I’m hoping we will commence UK, Belgium, or Germany, before a potential CR and my other hope is that if these treatments start , a Pharma may step in and put funds on the table so that a CR is not even required early next year
these are my personal opinions only
OSL Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)